FIG 1 pks-harboring E. coli strains exhibit antibiotic activities in an agar diffusion test (A) and in growth competition experiments (B). (A) The tested S. aureus strains were spread on LB agar, and bacterial pellets of E. coli DH10␤ (a), E. coli DH10␤ pks ϩ (b), and E. coli DH10␤ pks ⌬clbP (c) were spotted. The white arrow indicates the growth inhibition zone. (B) Growth competition between E. coli DH10␤ pks ϩ or E. coli DH10␤ and S. aureus strains susceptible or resistant to the antibiotic activity conferred by the pks island. After 24 h of coculture in LB medium, serial dilutions were spread on LB agar and S. aureus colonies were counted. Data are expressed as numbers of CFU per milliliter. **, P Ͻ 0.01.
T he pks genomic island present in Escherichia coli encodes polyketides (PK) and nonribosomal peptide (NRP) synthases. As discussed in an elegant study published recently (1) , this leads to the synthesis of numerous and still not fully purified and characterized PK-NRP compounds that confer to pks-harboring bacteria the ability to hijack host cell responses and to persist in the gut microbiota (2) (3) (4) (5) . Although the PK-NRP chemical family includes compounds used as antibiotics, such as ␤-lactams, glycopeptides, or daptomycin (6), there have been no studies of the antibiotic activity conferred by the pks island.
We studied bacterial growth inhibition using an antibiogram method derived from agar disc diffusion (7) . We used as putative antibiotic sources three laboratory E. coli DH10␤ strains hosting the empty bacterial artificial chromosome pBeloBAC11 (E. coli DH10␤) (2), pBeloBAC11 in which the pks island had been cloned (E. coli DH10␤ pks ϩ ) (2), or pBeloBAC11 containing a pks island with a deletion of clbP (E. coli DH10␤ pks ⌬clbP) (8) , which encodes an enzyme required for pks island biological activities (1, 9) . One hundred twenty-eight clinical strains belonging to 30 species were tested as reporter strains of antibiotic activity. These clinical strains were spread on Mueller-Hinton agar on which bacterial pellets of E. coli DH10␤ strains had been spotted. The presence of an inhibition zone around the pellet was assessed after 18 h of incubation at 37°C.
Interestingly, growth inhibition around the E. coli DH10␤ pks ϩ pellet was observed for 96% (n ϭ 52/54) of Staphylococcus aureus strains but was not observed around E. coli DH10␤ or E. coli DH10␤ pks ⌬clbP pellets ( Table 1 and Fig. 1A ). Inhibition was restricted to S. aureus species. To provide further evidence of this antibiotic activity, growth competition experiments were performed using resistant and susceptible S. aureus isolates. Unlike E. coli DH10␤, E. coli DH10␤ pks ϩ decreased the growth of susceptible S. aureus strains (Fig. 1B) .
Our results indicate that some of the compounds synthesized from the pks island exhibit antibiotic activity against pathogenic S. aureus species, including multiresistant isolates (see Tables S1 and S2 in the supplemental material). Interestingly, antibiotic activity was observed for 94% of methicillin-resistant S. aureus strains (n ϭ 30/32). The growth of all S. aureus strains presenting reduced susceptibility to glycopeptides was also inhibited by the E. coli DH10␤ pks ϩ strain (n ϭ 7/7). Finally, the growth of strains resistant to "last-resort" antistaphylococcal antibiotics, such as linezolid or daptomycin, was also affected by E. coli DH10␤ pks ϩ (n ϭ 2/3 and 5/6, respectively).
Antibiotic activity conferred by the pks island required live bacteria, since E. coli DH10␤ pks ϩ bacteria treated by chemical (chloroform or antibiotics) or physical (heat or sonication) processes did not inhibit S. aureus growth (data not shown). Furthermore, no antistaphylococcal effect was observed with the E. coli DH10␤ pks ⌬clbP strain, suggesting that the antibiotic compound needs to be matured by ClbP peptidase.
All together, our data suggest that the pks island produces antibiotics with enhanced activities against S. aureus strains, including multiresistant strains. We cannot exclude the possibility that the purified compound has a wider action spectrum than that discussed here. The challenge now is to purify those compounds in order to identify those responsible for this activity and to characterize more deeply their antistaphylococcal properties.
